Continuous electrocardiogram monitoring in porcine model of myocardial ischemia reperfusion

Abstract

As cardiovascular disease is the leading cause of global mortality, innovative animal models are vital to demonstrating the translational value of experimental discoveries. Investigations focused on myocardial remodeling after ischemia reperfusion (I/R) are well suited to a porcine model, but the evolution of that injury and its impact on electrical conductivity or arrhythmia threshold have been difficult to monitor continuously. Multiple electrode telemetry devices may be fitted to the animals but are costly and prone to damage. Implantable telemetry devices are likewise expensive, carry surgical risk, and are often verified only for single use. Here, we report the utilization of the commercially available Fourth Frontier X2 external telemetry device for continuous monitoring of heart rate and rhythm after myocardial I/R injury in pigs, highlighting sustained monitoring across a 7-day study.

Keywords

biotechnology / cardiovascular biology / veterinary research

References

[1] Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019. J Am Coll Cardiol. 2020; 76: 2982-3021.

[2] Martin SS, Aday AW, Almarzooq ZI, et al. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2024; 149: e347-e913.

[3] Edwards AG, Louch WE. Species-dependent mechanisms of cardiac arrhythmia: a cellular focus. Clin Med Insights. 2017; 11:1179546816686061.

[4] Silva KAS, Emter CA. Large animal models of heart failure: a translational bridge to clinical success. JACC Basic Transl Sci. 2020; 5: 840-856.

[5] Houser SR, Margulies KB, Murphy AM, et al. Animal models of heart failure. Circ Res. 2012; 111: 131-150.

[6] Zimmermann W-H, Melnychenko I, Wasmeier G, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med. 2006; 12: 452-458.

[7] Tan Y, Coyle RC, Barrs RW, et al. Nanowired human cardiac organoid transplantation enables highly efficient and effective recovery of infarcted hearts. Sci Adv. 2023; 9:eadf2898.

[8] Weinberger F, Breckwoldt K, Pecha S, et al. Cardiac repair in Guinea pigs with human engineered heart tissue from induced pluripotent stem cells. Sci Transl Med. 2016; 8:363ra148.

[9] Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007; 25: 1015-1024.

[10] Blackwell DJ, Schmeckpeper J, Knollmann BC. Animal models to study cardiac arrhythmias. Circ Res. 2022; 130: 1926-1964.

[11] Gao L, Gregorich ZR, Zhu W, et al. Large cardiac muscle patches engineered from human induced-pluripotent stem cell–derived cardiac cells improve recovery from myocardial infarction in swine. Circulation. 2018; 137: 1712-1730.

[12] Liu Y-W, Chen B, Yang X, et al. Human embryonic stem cell–derived cardiomyocytes restore function in infarcted hearts of non-human primates. Nat Biotechnol. 2018; 36: 597-605.

[13] Romagnuolo R, Masoudpour H, Porta-Sánchez A, et al. Human embryonic stem cell-derived Cardiomyocytes regenerate the infarcted pig heart but induce ventricular Tachyarrhythmias. Stem Cell Reports. 2019; 12: 967-981.

[14] Yap L, Chong LY, Tan C, et al. Pluripotent stem cell-derived committed cardiac progenitors remuscularize damaged ischemic hearts and improve their function in pigs. NPJ Regen Med. 2023; 8:26.

[15] Selvakumar D, Clayton ZE, Prowse A, et al. Cellular heterogeneity of pluripotent stem cell-derived cardiomyocyte grafts is mechanistically linked to treatable arrhythmias. Nat Cardiovasc Res. 2024; 3: 145-165.

[16] Zhang JJ, Pogwizd SM, Fukuda K, et al. Trials and tribulations of cell therapy for heart failure: an update on ongoing trials. Nat Rev Cardiol. 2024; 22: 372-385.

[17] Krause A, Zebunke M, Bellmann O, Mohr E, Langbein J, Puppe B. Surgical implantation and functional assessment of an invasive telemetric system to measure autonomic responses in domestic pigs. Vet J. 2016; 207: 140-146.

[18] Roberts WO, Levine BD. Wearables as an aid to cardiovascular diagnosis in a young runner. Curr Sports Med Rep. 2022; 21: 420-426.

[19] Eckhouse SR, Akerman AW, Logdon CB, et al. Differential membrane type 1 matrix metalloproteinase substrate processing with ischemia–reperfusion: relationship to interstitial microRNA dynamics and myocardial function. J Thorac Cardiovasc Surg. 2013; 145: 267-277.e264.

[20] Eckhouse SR, Purcell BP, McGarvey J, et al. Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction. Sci Transl Med. 2014; 6:223ra221.

[21] Yarbrough WM, Mukherjee R, Stroud RE, et al. Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature. J Thorac Cardiovasc Surg. 2012; 143: 215-223.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.